Published on in Vol 24, No 6 (2022): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33446, first published .
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

Rawa Kamaran Ismail   1 * , PhD, PharmD ;   Jesper van Breeschoten   2 * , PharmD ;   Silvia van der Flier   3 , PhD ;   Caspar van Loosen   4 , MSc ;   Anna Maria Gerdina Pasmooij   5 , PhD ;   Maaike van Dartel   5 , PhD ;   Alfons van den Eertwegh   6 , PhD, MD ;   Anthonius de Boer   1 , MD, PhD ;   Michel Wouters   7 , MD, PhD ;   Doranne Hilarius   8 , PhD, PharmD

1 Division of Pharmacoepidemiology and Clinical Pharmacology, University of Utrecht, Utrecht, Netherlands

2 Dutch Institute for Clinical Auditing, Leiden, Netherlands

3 Stichting Volksgezondheidszorg (VGZ), Arnhem, Netherlands

4 Dutch Association of Hospital Pharmacists, De Meern, Netherlands

5 Medicines Evaluation Board, Utrecht, Netherlands

6 Department of Medical Oncology, Amsterdam University Medical Center, location VUmc, Amsterdam, Netherlands

7 Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands

8 Rode Kruis Ziekenhuis, Beverwijk, Netherlands

*these authors contributed equally

Corresponding Author: